578 related articles for article (PubMed ID: 12056720)
1. Evolution of cell phenotype and extracellular matrix in tissue-engineered heart valves during in-vitro maturation and in-vivo remodeling.
Rabkin E; Hoerstrup SP; Aikawa M; Mayer JE; Schoen FJ
J Heart Valve Dis; 2002 May; 11(3):308-14; discussion 314. PubMed ID: 12056720
[TBL] [Abstract][Full Text] [Related]
2. Dynamic and reversible changes of interstitial cell phenotype during remodeling of cardiac valves.
Rabkin-Aikawa E; Farber M; Aikawa M; Schoen FJ
J Heart Valve Dis; 2004 Sep; 13(5):841-7. PubMed ID: 15473488
[TBL] [Abstract][Full Text] [Related]
3. Human cardiac valve interstitial cells in collagen sponge: a biological three-dimensional matrix for tissue engineering.
Taylor PM; Allen SP; Dreger SA; Yacoub MH
J Heart Valve Dis; 2002 May; 11(3):298-306; discussion 306-7. PubMed ID: 12056719
[TBL] [Abstract][Full Text] [Related]
4. Comparative study of cellular and extracellular matrix composition of native and tissue engineered heart valves.
Schenke-Layland K; Riemann I; Opitz F; König K; Halbhuber KJ; Stock UA
Matrix Biol; 2004 May; 23(2):113-25. PubMed ID: 15246110
[TBL] [Abstract][Full Text] [Related]
5. The in vitro development of autologous fibrin-based tissue-engineered heart valves through optimised dynamic conditioning.
Flanagan TC; Cornelissen C; Koch S; Tschoeke B; Sachweh JS; Schmitz-Rode T; Jockenhoevel S
Biomaterials; 2007 Aug; 28(23):3388-97. PubMed ID: 17467792
[TBL] [Abstract][Full Text] [Related]
6. Tissue engineering of autologous human heart valves using cryopreserved vascular umbilical cord cells.
Sodian R; Lueders C; Kraemer L; Kuebler W; Shakibaei M; Reichart B; Daebritz S; Hetzer R
Ann Thorac Surg; 2006 Jun; 81(6):2207-16. PubMed ID: 16731156
[TBL] [Abstract][Full Text] [Related]
7. Tissue engineering of functional trileaflet heart valves from human marrow stromal cells.
Hoerstrup SP; Kadner A; Melnitchouk S; Trojan A; Eid K; Tracy J; Sodian R; Visjager JF; Kolb SA; Grunenfelder J; Zund G; Turina MI
Circulation; 2002 Sep; 106(12 Suppl 1):I143-50. PubMed ID: 12354724
[TBL] [Abstract][Full Text] [Related]
8. The independent role of cyclic flexure in the early in vitro development of an engineered heart valve tissue.
Engelmayr GC; Rabkin E; Sutherland FW; Schoen FJ; Mayer JE; Sacks MS
Biomaterials; 2005 Jan; 26(2):175-87. PubMed ID: 15207464
[TBL] [Abstract][Full Text] [Related]
9. Minimally-invasive implantation of living tissue engineered heart valves: a comprehensive approach from autologous vascular cells to stem cells.
Schmidt D; Dijkman PE; Driessen-Mol A; Stenger R; Mariani C; Puolakka A; Rissanen M; Deichmann T; Odermatt B; Weber B; Emmert MY; Zund G; Baaijens FP; Hoerstrup SP
J Am Coll Cardiol; 2010 Aug; 56(6):510-20. PubMed ID: 20670763
[TBL] [Abstract][Full Text] [Related]
10. [A xenogeneic acellularized matrix for heart valve tissue engineering: in vivo study in a sheep model].
Leyh R; Wilhelmi M; Haverich A; Mertsching H
Z Kardiol; 2003 Nov; 92(11):938-46. PubMed ID: 14634763
[TBL] [Abstract][Full Text] [Related]
11. From stem cells to viable autologous semilunar heart valve.
Sutherland FW; Perry TE; Yu Y; Sherwood MC; Rabkin E; Masuda Y; Garcia GA; McLellan DL; Engelmayr GC; Sacks MS; Schoen FJ; Mayer JE
Circulation; 2005 May; 111(21):2783-91. PubMed ID: 15927990
[TBL] [Abstract][Full Text] [Related]
12. Prenatally fabricated autologous human living heart valves based on amniotic fluid derived progenitor cells as single cell source.
Schmidt D; Achermann J; Odermatt B; Breymann C; Mol A; Genoni M; Zund G; Hoerstrup SP
Circulation; 2007 Sep; 116(11 Suppl):I64-70. PubMed ID: 17846327
[TBL] [Abstract][Full Text] [Related]
13. Human semilunar cardiac valve remodeling by activated cells from fetus to adult: implications for postnatal adaptation, pathology, and tissue engineering.
Aikawa E; Whittaker P; Farber M; Mendelson K; Padera RF; Aikawa M; Schoen FJ
Circulation; 2006 Mar; 113(10):1344-52. PubMed ID: 16534030
[TBL] [Abstract][Full Text] [Related]
14. Tissue engineering of heart valves: biomechanical and morphological properties of decellularized heart valves.
Tudorache I; Cebotari S; Sturz G; Kirsch L; Hurschler C; Hilfiker A; Haverich A; Lichtenberg A
J Heart Valve Dis; 2007 Sep; 16(5):567-73; discussion 574. PubMed ID: 17944130
[TBL] [Abstract][Full Text] [Related]
15. Cyclic flexure and laminar flow synergistically accelerate mesenchymal stem cell-mediated engineered tissue formation: Implications for engineered heart valve tissues.
Engelmayr GC; Sales VL; Mayer JE; Sacks MS
Biomaterials; 2006 Dec; 27(36):6083-95. PubMed ID: 16930686
[TBL] [Abstract][Full Text] [Related]
16. In vivo remodeling and structural characterization of fibrin-based tissue-engineered heart valves in the adult sheep model.
Flanagan TC; Sachweh JS; Frese J; Schnöring H; Gronloh N; Koch S; Tolba RH; Schmitz-Rode T; Jockenhoevel S
Tissue Eng Part A; 2009 Oct; 15(10):2965-76. PubMed ID: 19320544
[TBL] [Abstract][Full Text] [Related]
17. Healing and remodeling of bioengineered pulmonary artery patches implanted in sheep.
Mendelson K; Aikawa E; Mettler BA; Sales V; Martin D; Mayer JE; Schoen FJ
Cardiovasc Pathol; 2007; 16(5):277-82. PubMed ID: 17868878
[TBL] [Abstract][Full Text] [Related]
18. Tissue-engineered heart valves. Autologous valve leaflet replacement study in a lamb model.
Shinoka T; Ma PX; Shum-Tim D; Breuer CK; Cusick RA; Zund G; Langer R; Vacanti JP; Mayer JE
Circulation; 1996 Nov; 94(9 Suppl):II164-8. PubMed ID: 8901739
[TBL] [Abstract][Full Text] [Related]
19. Cryopreserved amniotic fluid-derived cells: a lifelong autologous fetal stem cell source for heart valve tissue engineering.
Schmidt D; Achermann J; Odermatt B; Genoni M; Zund G; Hoerstrup SP
J Heart Valve Dis; 2008 Jul; 17(4):446-55; discussion 455. PubMed ID: 18751475
[TBL] [Abstract][Full Text] [Related]
20. Vascular smooth muscle cells as a valvular interstitial cell surrogate in heart valve tissue engineering.
Appleton AJ; Appleton CT; Boughner DR; Rogers KA
Tissue Eng Part A; 2009 Dec; 15(12):3889-97. PubMed ID: 19563261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
